[Mitochondrial cardiomyopathy].
Tanaka
Masashi
M
Department of Gene Therapy, Gifu International Institute of Biotechnology.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000235:genetics; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000235:genetics; D003573:Cytochrome b Group / Q000235:genetics; D004272:DNA, Mitochondrial / Q000235:genetics; D003937:Diagnosis, Differential; D015316:Genetic Therapy; D016027:Heart Transplantation; D006801:Humans; D017240:Mitochondrial Myopathies / Q000175:diagnosis / Q000235:genetics; D009154:Mutation; D012313:RNA / Q000235:genetics; D000077278:RNA, Mitochondrial; D012343:RNA, Transfer / Q000235:genetics; D014451:Ubiquinone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D003573:Cytochrome b Group; D004272:DNA, Mitochondrial; D000077278:RNA, Mitochondrial; D014451:Ubiquinone; D012313:RNA; D012343:RNA, Transfer